Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

Jens G. Lohr(Broad Institute), Petar Stojanov(Broad Institute), Scott L. Carter(Broad Institute), Peter Cruz‐Gordillo(Broad Institute), Michael S. Lawrence(Broad Institute), Daniel Auclair(Broad Institute), Carrie Sougnez(Broad Institute), Birgit Knoechel(Broad Institute), Joshua Gould(Broad Institute), Gordon Saksena(Broad Institute), Kristian Cibulskis(Broad Institute), Aaron McKenna(Broad Institute), Michael A. Chapman(Addenbrooke's Hospital), Ravid Straussman(Broad Institute), Joan Levy(Multiple Myeloma Research Foundation), Louise M. Perkins(Multiple Myeloma Research Foundation), Jonathan J. Keats(Translational Genomics Research Institute), Steven E. Schumacher(Broad Institute), Mara Rosenberg(Broad Institute), Gad Getz(Broad Institute), Todd R. Golub(Broad Institute), Kenneth C. Anderson, Paul G. Richardson, Amrita Krishnan, Sagar Lonial, Jonathan L. Kaufman(Translational Genomics Research Institute), David S. Siegel, D. H. Vesole, Vivek Roy, Candido E. Rivera, S. Vincent Rajkumar, Shaji Kumar, Rafaël Fonseca, Greg Ahmann, P. Leif Bergsagel, A. Keith Stewart, Craig C. Hofmeister, Yvonne A. Efebera, Sundar Jagannath, Ajai Chari, Suzanne Trudel, Donna Reece, Jeffrey Wolf, Thomas Martin, Todd M. Zimmerman(Broad Institute), Cara A. Rosenbaum, Andrzej Jakubowiak, Daniel Lebovic(Broad Institute), Ravi Vij(Broad Institute), Keith Stockerl-Goldstein
Cancer Cell
January 1, 2014
Cited by 1,003Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis